EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2

Andrea Varrone, Susanne Asenbaum, Thierry Vander Borght, Jan Booij, Flavio Nobili, Kjell Någren, Jacques Darcourt, Özlem L. Kapucu, Klaus Tatsch, Peter Bartenstein, Koen Van Laere

Research output: Contribution to journalReview articlepeer-review

Abstract

These guidelines summarize the current views of the European Association of Nuclear Medicine Neuroimaging Committee (ENC). The purpose of the guidelines is to assist nuclear medicine practitioners in making recommendations, performing, interpreting, and reporting the results of fluorine-18 fluoro-2-deoxyglucose ([18F]FDG) PET imaging of the brain. The aim is to help achieve a high standard of FDG imaging, which will increase the diagnostic impact of this technique in neurological and psychiatric practice. The present document replaces a former version of the guidelines that were published in 2002 [1] and includes an update in the light of advances in PET technology, the introduction of hybrid PET/CT systems and the broadening clinical indications for FDG brain imaging. These guidelines are intended to present information specifically adapted for European practice. The information provided should be taken in the context of local conditions and regulations.

Original languageEnglish
Pages (from-to)2103-2110
Number of pages8
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume36
Issue number12
DOIs
Publication statusPublished - Dec 1 2009

Keywords

  • Dementia
  • Epilepsy
  • Glucose
  • Metabolism
  • Movement disorders
  • Oncology
  • PET

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'EANM procedure guidelines for PET brain imaging using [<sup>18</sup>F]FDG, version 2'. Together they form a unique fingerprint.

Cite this